Psoriasis and Arthritis Drugs Get Nod From EMA ' s CHMP Psoriasis and Arthritis Drugs Get Nod From EMA ' s CHMP

Tofacitinib citrate (Xeljanz), two adalimumab (Humira) biosimilars, and one methotrexate hybrid get thumbs up from EMA committee.International Approvals
Source: Medscape Pharmacist Headlines - Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news